Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Multiple Myeloma 2Depression 2Breast Neoplasms 2Anxiety Disorders 2Uveal Melanoma 1Small Cell Lung Carcinoma 1Prolactin-Producing Pituitary Tumor 1Pituitary ACTH Hypersecretion 1Neoplasms 1Neoplasm Metastasis 1Metastatic Solid Tumor Cancers 1Lung Neoplasms 1Glioma 1Glioblastoma 1Cushing Syndrome 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cancer Caregivers 1

Interventions

pasireotide 14-amino-4'-hydroxylaminodiphenylsulfone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prolactin-Producing Pituitary Tumor × 4-amino-4'-hydroxylaminodiphenylsulfone × Clear all
NCT06295952 2026-03-04

A Study of Pasireotide in People With Prolactinoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
10 enrolled
Endocrine

Prolactin-Producing Pituitary Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡